|
Index of reports
> Cases resulting in other serious reactions (78)
> Cases with Pancytopenia (5)
Below is the selection of adverse event reports related to Cozaar (Losartan) that includes cases resulting in other serious reactions where reactions include pancytopenia.
Adverse event in receiving Cozaar (Losartan)
Reported by a pharmacist from Japan on 2007-10-19
Patient:
Adverse reactions / side effects: Pancytopenia
Suspect drug(s):
Cozaar (Losartan)
Other drugs received by patient: [therapy Unspecified]
Adverse event in 77 year old female receiving Cozaar (Losartan)
Reported by a pharmacist from Japan on 2007-10-01
Patient: 77 year old female
Adverse reactions / side effects: Pancytopenia
Suspect drug(s):
Cozaar
Administration route: Oral
Lasix
Other drugs received by patient: Urso 250; Thyradin; Rabeprazole Sodium; Kalgut
Adverse event in 51 year old female receiving Cozaar (Losartan)
Reported by a physician from Japan on 2007-05-30
Patient: 51 year old female, weighing 50.0 kg (110.0 pounds)
Adverse reactions / side effects: Pancytopenia
Suspect drug(s):
Cozaar
Administration route: Oral
Indication: Hypertension
Start date: 2006-11-16
End date: 2007-05-07
Cozaar
Administration route: Oral
Start date: 2007-01-01
Lipitor
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2006-11-16
End date: 2007-03-16
Adverse event in 51 year old female receiving Cozaar (Losartan)
Reported by a physician from Japan on 2007-05-18
Patient: 51 year old female
Adverse reactions / side effects: Pancytopenia
Suspect drug(s):
Cozaar
Administration route: Oral
Indication: Hypertension
Start date: 2006-11-16
End date: 2007-03-01
Cozaar
Administration route: Oral
Start date: 2007-01-01
Lipitor
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2007-02-02
End date: 2007-03-01
Adverse event in 51 year old female receiving Cozaar (Losartan)
Reported by a physician from Japan on 2007-03-13
Patient: 51 year old female
Adverse reactions / side effects: Pancytopenia
Suspect drug(s):
Cozaar
Administration route: Oral
Indication: Hypertension
Start date: 2006-11-16
End date: 2007-03-01
Lipitor
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2007-02-02
End date: 2007-03-01
|
